| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Flow Velocity | 41 | 2021 | 439 | 1.870 |
Why?
|
| Ultrasonography, Doppler | 13 | 2015 | 186 | 1.450 |
Why?
|
| Image Interpretation, Computer-Assisted | 8 | 2010 | 228 | 1.160 |
Why?
|
| Pulsatile Flow | 10 | 2011 | 124 | 0.920 |
Why?
|
| Signal Processing, Computer-Assisted | 5 | 2012 | 131 | 0.910 |
Why?
|
| Aorta | 12 | 2021 | 550 | 0.890 |
Why?
|
| Coronary Circulation | 33 | 2009 | 206 | 0.890 |
Why?
|
| Hemodynamics | 39 | 2011 | 852 | 0.820 |
Why?
|
| Laser-Doppler Flowmetry | 3 | 2011 | 62 | 0.760 |
Why?
|
| Arteries | 6 | 2011 | 222 | 0.750 |
Why?
|
| Coronary Vessels | 13 | 2010 | 549 | 0.740 |
Why?
|
| Isoflurane | 9 | 2009 | 38 | 0.740 |
Why?
|
| Carotid Arteries | 11 | 2015 | 135 | 0.690 |
Why?
|
| Vascular Resistance | 16 | 2009 | 196 | 0.670 |
Why?
|
| Aging | 15 | 2015 | 1248 | 0.640 |
Why?
|
| Transducers | 3 | 2009 | 22 | 0.610 |
Why?
|
| Ultrasonography, Doppler, Pulsed | 4 | 2009 | 21 | 0.570 |
Why?
|
| Cardiomegaly | 5 | 2008 | 125 | 0.560 |
Why?
|
| Hemorheology | 4 | 2008 | 25 | 0.550 |
Why?
|
| Apolipoproteins E | 4 | 2009 | 200 | 0.530 |
Why?
|
| Models, Cardiovascular | 10 | 2011 | 184 | 0.530 |
Why?
|
| Echocardiography, Doppler, Pulsed | 3 | 2021 | 16 | 0.520 |
Why?
|
| Animals | 134 | 2021 | 34789 | 0.500 |
Why?
|
| Mice | 43 | 2021 | 18461 | 0.490 |
Why?
|
| Blood Pressure Determination | 3 | 2011 | 116 | 0.470 |
Why?
|
| Regional Blood Flow | 28 | 2011 | 212 | 0.460 |
Why?
|
| Heart | 18 | 2007 | 690 | 0.420 |
Why?
|
| Dogs | 75 | 2008 | 656 | 0.420 |
Why?
|
| Myocardial Contraction | 18 | 2021 | 256 | 0.410 |
Why?
|
| Ventricular Function, Left | 4 | 2021 | 551 | 0.390 |
Why?
|
| Thermography | 2 | 2009 | 12 | 0.380 |
Why?
|
| Preventive Health Services | 1 | 2012 | 63 | 0.370 |
Why?
|
| Blood Volume | 4 | 2010 | 80 | 0.370 |
Why?
|
| Vasodilator Agents | 5 | 2010 | 207 | 0.350 |
Why?
|
| Medical Informatics | 1 | 2012 | 110 | 0.350 |
Why?
|
| Cardiac Catheterization | 6 | 2008 | 661 | 0.340 |
Why?
|
| Equipment Design | 7 | 2011 | 602 | 0.340 |
Why?
|
| Anesthetics, Inhalation | 3 | 2009 | 46 | 0.330 |
Why?
|
| Cardiovascular Diseases | 3 | 2012 | 2091 | 0.330 |
Why?
|
| Aortic Valve Stenosis | 2 | 2005 | 377 | 0.330 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2009 | 20 | 0.300 |
Why?
|
| Ventricular Function | 4 | 2008 | 91 | 0.290 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2009 | 53 | 0.290 |
Why?
|
| Coronary Disease | 18 | 2009 | 684 | 0.280 |
Why?
|
| Ultrasonography | 17 | 2015 | 988 | 0.280 |
Why?
|
| Disease Models, Animal | 13 | 2011 | 4683 | 0.280 |
Why?
|
| Equipment Failure Analysis | 4 | 2009 | 84 | 0.260 |
Why?
|
| Mitral Valve Insufficiency | 4 | 2011 | 185 | 0.260 |
Why?
|
| Echocardiography, Three-Dimensional | 5 | 2011 | 58 | 0.250 |
Why?
|
| Ultrasonics | 10 | 2000 | 36 | 0.250 |
Why?
|
| Diastole | 8 | 2015 | 181 | 0.240 |
Why?
|
| Mitral Valve | 5 | 2011 | 269 | 0.240 |
Why?
|
| Arterial Occlusive Diseases | 3 | 2005 | 119 | 0.240 |
Why?
|
| Age Factors | 5 | 2015 | 2913 | 0.240 |
Why?
|
| Myocardium | 16 | 2008 | 907 | 0.240 |
Why?
|
| Vasodilation | 8 | 2010 | 182 | 0.230 |
Why?
|
| Fingers | 4 | 2009 | 66 | 0.230 |
Why?
|
| Echocardiography, Doppler, Color | 4 | 2009 | 115 | 0.220 |
Why?
|
| Mice, Inbred C57BL | 15 | 2021 | 4752 | 0.220 |
Why?
|
| Biomedical Engineering | 3 | 2009 | 24 | 0.220 |
Why?
|
| Carotid Artery Diseases | 4 | 2015 | 137 | 0.220 |
Why?
|
| Motion | 1 | 2004 | 44 | 0.220 |
Why?
|
| Hyperemia | 3 | 2009 | 35 | 0.220 |
Why?
|
| Blood Pressure | 31 | 2011 | 1400 | 0.210 |
Why?
|
| Echocardiography, Doppler | 3 | 2001 | 172 | 0.200 |
Why?
|
| Monitoring, Physiologic | 5 | 2002 | 377 | 0.200 |
Why?
|
| Systole | 10 | 2008 | 206 | 0.190 |
Why?
|
| Vascular Stiffness | 2 | 2015 | 81 | 0.190 |
Why?
|
| Surgical Flaps | 4 | 2010 | 189 | 0.190 |
Why?
|
| Arteriosclerosis | 2 | 2000 | 123 | 0.180 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2002 | 27 | 0.180 |
Why?
|
| Reproducibility of Results | 8 | 2013 | 3011 | 0.180 |
Why?
|
| Atherosclerosis | 1 | 2010 | 1007 | 0.180 |
Why?
|
| Myocardial Reperfusion | 7 | 2008 | 56 | 0.180 |
Why?
|
| Aorta, Thoracic | 2 | 1997 | 540 | 0.180 |
Why?
|
| Heart Rate | 30 | 2002 | 588 | 0.170 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 2 | 2011 | 34 | 0.170 |
Why?
|
| Muscle, Smooth, Vascular | 5 | 2011 | 238 | 0.170 |
Why?
|
| Mice, Knockout | 7 | 2011 | 3860 | 0.160 |
Why?
|
| Echocardiography | 7 | 2011 | 1129 | 0.160 |
Why?
|
| Sensitivity and Specificity | 5 | 2015 | 2140 | 0.150 |
Why?
|
| Tantalum | 1 | 1999 | 7 | 0.150 |
Why?
|
| Radioisotopes | 1 | 1999 | 27 | 0.150 |
Why?
|
| Nitric Oxide | 4 | 2010 | 471 | 0.150 |
Why?
|
| Myocardial Ischemia | 5 | 2008 | 343 | 0.140 |
Why?
|
| Anesthetics | 3 | 2008 | 79 | 0.140 |
Why?
|
| Pulse | 1 | 1997 | 27 | 0.140 |
Why?
|
| Liver | 15 | 1998 | 1796 | 0.140 |
Why?
|
| omega-N-Methylarginine | 6 | 2008 | 11 | 0.130 |
Why?
|
| Manometry | 1 | 1997 | 72 | 0.130 |
Why?
|
| Mice, Mutant Strains | 3 | 2013 | 378 | 0.130 |
Why?
|
| Hypertension | 4 | 2013 | 1396 | 0.130 |
Why?
|
| Electrocardiography | 8 | 2009 | 1014 | 0.130 |
Why?
|
| Aorta, Abdominal | 1 | 1997 | 118 | 0.130 |
Why?
|
| Heart Atria | 3 | 2015 | 340 | 0.130 |
Why?
|
| Transducers, Pressure | 3 | 2011 | 11 | 0.130 |
Why?
|
| Insulin | 14 | 1998 | 1168 | 0.120 |
Why?
|
| Algorithms | 4 | 2011 | 1721 | 0.120 |
Why?
|
| Heart Failure, Diastolic | 1 | 2015 | 10 | 0.120 |
Why?
|
| Atrial Function, Left | 1 | 2015 | 31 | 0.120 |
Why?
|
| Pulmonary Artery | 2 | 2015 | 457 | 0.110 |
Why?
|
| Postprandial Period | 1 | 2015 | 90 | 0.110 |
Why?
|
| Energy Intake | 1 | 1997 | 493 | 0.110 |
Why?
|
| Albumins | 2 | 2005 | 95 | 0.110 |
Why?
|
| Hematopoiesis | 5 | 2001 | 224 | 0.110 |
Why?
|
| Vasoconstriction | 4 | 2011 | 104 | 0.100 |
Why?
|
| Dietary Fats | 1 | 2015 | 279 | 0.100 |
Why?
|
| Hyperlipidemias | 1 | 2015 | 188 | 0.100 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2013 | 323 | 0.100 |
Why?
|
| Anastomosis, Surgical | 3 | 2010 | 167 | 0.100 |
Why?
|
| Aging, Premature | 1 | 2013 | 28 | 0.100 |
Why?
|
| Cardiac Pacing, Artificial | 3 | 2004 | 129 | 0.100 |
Why?
|
| Shock, Septic | 2 | 2008 | 154 | 0.100 |
Why?
|
| Growth Hormone | 1 | 2013 | 129 | 0.100 |
Why?
|
| Fourier Analysis | 2 | 2008 | 60 | 0.100 |
Why?
|
| Monitoring, Ambulatory | 1 | 2012 | 58 | 0.090 |
Why?
|
| Glucose | 9 | 1998 | 870 | 0.090 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2013 | 93 | 0.090 |
Why?
|
| Male | 53 | 2021 | 64910 | 0.090 |
Why?
|
| Heart Function Tests | 2 | 2009 | 56 | 0.090 |
Why?
|
| Liver Circulation | 7 | 1992 | 19 | 0.090 |
Why?
|
| Enzyme Inhibitors | 5 | 2008 | 589 | 0.090 |
Why?
|
| Prostaglandins | 3 | 1990 | 43 | 0.090 |
Why?
|
| Potassium | 3 | 2010 | 275 | 0.090 |
Why?
|
| Artificial Intelligence | 2 | 2005 | 298 | 0.090 |
Why?
|
| Glucagon | 9 | 1998 | 151 | 0.090 |
Why?
|
| Laser Therapy | 1 | 1994 | 232 | 0.090 |
Why?
|
| Verapamil | 6 | 1989 | 52 | 0.090 |
Why?
|
| Miniaturization | 1 | 2011 | 26 | 0.090 |
Why?
|
| Carotid Artery, Common | 1 | 2011 | 66 | 0.090 |
Why?
|
| Contrast Media | 2 | 2005 | 507 | 0.090 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2005 | 219 | 0.090 |
Why?
|
| Computer Systems | 2 | 2009 | 38 | 0.080 |
Why?
|
| Cardiac Output | 11 | 2001 | 166 | 0.080 |
Why?
|
| Humans | 40 | 2015 | 131985 | 0.080 |
Why?
|
| Veins | 1 | 2010 | 104 | 0.080 |
Why?
|
| Feasibility Studies | 2 | 2010 | 822 | 0.080 |
Why?
|
| Basilar Artery | 1 | 2010 | 26 | 0.080 |
Why?
|
| Diagnostic Imaging | 1 | 2012 | 313 | 0.080 |
Why?
|
| Tachycardia | 1 | 1990 | 69 | 0.080 |
Why?
|
| Coronary Artery Disease | 2 | 2009 | 893 | 0.080 |
Why?
|
| Blood Glucose | 11 | 1998 | 1121 | 0.080 |
Why?
|
| Rheology | 3 | 1985 | 32 | 0.080 |
Why?
|
| Hydrops Fetalis | 1 | 1990 | 85 | 0.080 |
Why?
|
| Myocardial Infarction | 4 | 2002 | 1046 | 0.080 |
Why?
|
| Nitroglycerin | 2 | 1990 | 23 | 0.080 |
Why?
|
| Skin Temperature | 1 | 2009 | 16 | 0.080 |
Why?
|
| Muscles | 3 | 1994 | 238 | 0.080 |
Why?
|
| Middle Cerebral Artery | 1 | 2010 | 115 | 0.080 |
Why?
|
| Models, Animal | 2 | 2008 | 469 | 0.080 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2011 | 377 | 0.080 |
Why?
|
| Hydralazine | 2 | 2001 | 8 | 0.080 |
Why?
|
| Halothane | 4 | 2001 | 11 | 0.070 |
Why?
|
| Nitric Oxide Synthase | 5 | 2002 | 175 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 5 | 2001 | 550 | 0.070 |
Why?
|
| Myocardial Reperfusion Injury | 4 | 2001 | 129 | 0.070 |
Why?
|
| Female | 44 | 2021 | 70623 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2008 | 93 | 0.070 |
Why?
|
| Coronary Stenosis | 1 | 2009 | 83 | 0.070 |
Why?
|
| Heart Ventricles | 5 | 2008 | 791 | 0.070 |
Why?
|
| Thrombopoietin | 2 | 1999 | 33 | 0.070 |
Why?
|
| Dobutamine | 3 | 2021 | 56 | 0.070 |
Why?
|
| Antihypertensive Agents | 2 | 2001 | 429 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2008 | 192 | 0.070 |
Why?
|
| Cerebrovascular Circulation | 2 | 2010 | 476 | 0.070 |
Why?
|
| Muscle, Smooth | 2 | 2004 | 131 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 246 | 0.070 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2009 | 158 | 0.070 |
Why?
|
| Species Specificity | 1 | 2008 | 541 | 0.060 |
Why?
|
| Lipopolysaccharides | 1 | 2008 | 306 | 0.060 |
Why?
|
| Swine | 4 | 2008 | 1181 | 0.060 |
Why?
|
| Guanidines | 2 | 2008 | 23 | 0.060 |
Why?
|
| Aortic Valve | 2 | 2008 | 483 | 0.060 |
Why?
|
| Enflurane | 4 | 1992 | 4 | 0.060 |
Why?
|
| Body Temperature | 2 | 2004 | 128 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2012 | 3736 | 0.060 |
Why?
|
| Vasa Vasorum | 1 | 2005 | 3 | 0.060 |
Why?
|
| Isoproterenol | 6 | 2001 | 97 | 0.060 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2006 | 93 | 0.060 |
Why?
|
| Time Factors | 11 | 2015 | 6443 | 0.060 |
Why?
|
| Hematopoietic Cell Growth Factors | 2 | 1995 | 11 | 0.060 |
Why?
|
| Constriction | 2 | 2003 | 47 | 0.060 |
Why?
|
| Renal Circulation | 7 | 1991 | 47 | 0.060 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2008 | 377 | 0.060 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 2 | 1995 | 95 | 0.050 |
Why?
|
| Saphenous Vein | 1 | 1984 | 53 | 0.050 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2004 | 70 | 0.050 |
Why?
|
| Phenotype | 4 | 2013 | 4526 | 0.050 |
Why?
|
| Adaptation, Physiological | 2 | 1990 | 271 | 0.050 |
Why?
|
| Cell Lineage | 3 | 2001 | 357 | 0.050 |
Why?
|
| Tail | 1 | 2003 | 13 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2011 | 923 | 0.050 |
Why?
|
| Microcirculation | 2 | 1993 | 117 | 0.050 |
Why?
|
| Ultrasonography, Interventional | 1 | 2005 | 208 | 0.050 |
Why?
|
| Alternative Splicing | 1 | 2005 | 363 | 0.050 |
Why?
|
| Portal Vein | 5 | 1998 | 88 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 1410 | 0.050 |
Why?
|
| Hematocrit | 2 | 2000 | 111 | 0.050 |
Why?
|
| Anesthetics, Intravenous | 1 | 2002 | 47 | 0.050 |
Why?
|
| Propofol | 1 | 2002 | 50 | 0.050 |
Why?
|
| Actins | 1 | 2004 | 334 | 0.050 |
Why?
|
| Rats | 7 | 2001 | 3608 | 0.050 |
Why?
|
| Ethylamines | 1 | 2001 | 2 | 0.050 |
Why?
|
| Organoselenium Compounds | 1 | 2001 | 5 | 0.050 |
Why?
|
| Thiopental | 2 | 1993 | 5 | 0.050 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2002 | 79 | 0.050 |
Why?
|
| Propranolol | 5 | 1996 | 112 | 0.050 |
Why?
|
| Heparin Antagonists | 1 | 2001 | 4 | 0.040 |
Why?
|
| Protamines | 1 | 2001 | 12 | 0.040 |
Why?
|
| Predictive Value of Tests | 3 | 2015 | 2317 | 0.040 |
Why?
|
| Body Weight | 2 | 2007 | 994 | 0.040 |
Why?
|
| Free Radicals | 4 | 1995 | 33 | 0.040 |
Why?
|
| Hepatic Artery | 3 | 1998 | 47 | 0.040 |
Why?
|
| Elasticity | 3 | 2006 | 78 | 0.040 |
Why?
|
| Acceleration | 1 | 2021 | 27 | 0.040 |
Why?
|
| Ventricular Pressure | 1 | 2021 | 38 | 0.040 |
Why?
|
| Angiotensin II | 3 | 1988 | 163 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2005 | 604 | 0.040 |
Why?
|
| Thallium | 1 | 2000 | 8 | 0.040 |
Why?
|
| Phenethylamines | 1 | 2000 | 17 | 0.040 |
Why?
|
| Technetium Tc 99m Sestamibi | 1 | 2000 | 26 | 0.040 |
Why?
|
| Ophthalmic Artery | 1 | 1980 | 23 | 0.040 |
Why?
|
| Leukopoiesis | 1 | 1999 | 3 | 0.040 |
Why?
|
| Splanchnic Circulation | 2 | 1998 | 51 | 0.040 |
Why?
|
| Vasoconstrictor Agents | 2 | 2011 | 141 | 0.040 |
Why?
|
| Desmin | 1 | 1999 | 20 | 0.040 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2001 | 1197 | 0.040 |
Why?
|
| Heparin | 1 | 2001 | 212 | 0.040 |
Why?
|
| Methyl Ethers | 2 | 1992 | 23 | 0.040 |
Why?
|
| Bone Marrow Cells | 1 | 2001 | 258 | 0.040 |
Why?
|
| Radiopharmaceuticals | 1 | 2000 | 170 | 0.040 |
Why?
|
| Anesthesia | 2 | 2002 | 216 | 0.040 |
Why?
|
| Adenosine | 1 | 2000 | 135 | 0.040 |
Why?
|
| Organ Size | 1 | 2000 | 447 | 0.040 |
Why?
|
| Orbit | 1 | 1980 | 84 | 0.040 |
Why?
|
| Radionuclide Ventriculography | 1 | 1999 | 4 | 0.040 |
Why?
|
| Gamma Cameras | 1 | 1999 | 5 | 0.040 |
Why?
|
| Spleen | 2 | 1997 | 270 | 0.040 |
Why?
|
| In Vitro Techniques | 2 | 1994 | 862 | 0.040 |
Why?
|
| Muscle Contraction | 2 | 1993 | 155 | 0.040 |
Why?
|
| Stroke Volume | 4 | 1999 | 541 | 0.040 |
Why?
|
| Heart Failure | 4 | 2002 | 2390 | 0.040 |
Why?
|
| Regeneration | 1 | 2001 | 226 | 0.040 |
Why?
|
| Ventricular Remodeling | 1 | 1999 | 167 | 0.040 |
Why?
|
| Potassium Chloride | 2 | 2011 | 48 | 0.040 |
Why?
|
| Myocardial Stunning | 2 | 1995 | 19 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2001 | 487 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 1999 | 251 | 0.040 |
Why?
|
| Rats, Inbred Strains | 2 | 1990 | 219 | 0.040 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 1999 | 158 | 0.030 |
Why?
|
| Cholesterol | 1 | 2000 | 558 | 0.030 |
Why?
|
| Octreotide | 1 | 1997 | 24 | 0.030 |
Why?
|
| Nicardipine | 2 | 1987 | 17 | 0.030 |
Why?
|
| Observer Variation | 2 | 2008 | 304 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2010 | 1672 | 0.030 |
Why?
|
| Cardiomyoplasty | 1 | 1996 | 6 | 0.030 |
Why?
|
| Anesthesia, Endotracheal | 2 | 1986 | 4 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2001 | 609 | 0.030 |
Why?
|
| Hyperthyroidism | 1 | 1996 | 24 | 0.030 |
Why?
|
| Stem Cells | 1 | 2001 | 732 | 0.030 |
Why?
|
| Leukocytes | 1 | 1997 | 209 | 0.030 |
Why?
|
| Mammals | 1 | 1997 | 272 | 0.030 |
Why?
|
| Drug Interactions | 6 | 2001 | 246 | 0.030 |
Why?
|
| Receptors, Cytokine | 1 | 1995 | 67 | 0.030 |
Why?
|
| Adult | 9 | 2015 | 31547 | 0.030 |
Why?
|
| Middle Aged | 8 | 2013 | 28976 | 0.030 |
Why?
|
| Megakaryocytes | 1 | 1995 | 43 | 0.030 |
Why?
|
| Regression Analysis | 1 | 1997 | 795 | 0.030 |
Why?
|
| Pulse Wave Analysis | 1 | 2015 | 52 | 0.030 |
Why?
|
| Arginine | 2 | 1996 | 343 | 0.030 |
Why?
|
| Lasalocid | 3 | 1982 | 3 | 0.030 |
Why?
|
| Injections, Intravenous | 2 | 1993 | 247 | 0.030 |
Why?
|
| Ligation | 3 | 2003 | 140 | 0.030 |
Why?
|
| Vitamin E | 1 | 1995 | 63 | 0.030 |
Why?
|
| Receptors, Immunologic | 1 | 1995 | 126 | 0.030 |
Why?
|
| Cardiovascular System | 2 | 1986 | 105 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2015 | 152 | 0.030 |
Why?
|
| Mice, Inbred Strains | 3 | 2003 | 308 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2001 | 1035 | 0.030 |
Why?
|
| Vena Cava, Superior | 1 | 1995 | 59 | 0.030 |
Why?
|
| Cattle | 2 | 1994 | 569 | 0.030 |
Why?
|
| Assisted Circulation | 1 | 1994 | 37 | 0.030 |
Why?
|
| Renin | 2 | 1985 | 96 | 0.030 |
Why?
|
| Organ Specificity | 2 | 2008 | 412 | 0.030 |
Why?
|
| Homeostasis | 2 | 1997 | 722 | 0.030 |
Why?
|
| Mice, Transgenic | 3 | 2005 | 2444 | 0.030 |
Why?
|
| Bone Marrow Transplantation | 4 | 2001 | 612 | 0.030 |
Why?
|
| Hemorrhage | 2 | 1993 | 519 | 0.030 |
Why?
|
| Femoral Artery | 3 | 1986 | 166 | 0.030 |
Why?
|
| Electric Stimulation Therapy | 1 | 1994 | 85 | 0.030 |
Why?
|
| Exercise Test | 2 | 2007 | 259 | 0.020 |
Why?
|
| Pilot Projects | 2 | 2015 | 1441 | 0.020 |
Why?
|
| Cardiac Surgical Procedures | 2 | 1993 | 1176 | 0.020 |
Why?
|
| Carotid Intima-Media Thickness | 1 | 2013 | 80 | 0.020 |
Why?
|
| Microspheres | 1 | 1993 | 72 | 0.020 |
Why?
|
| Catheterization | 1 | 1974 | 241 | 0.020 |
Why?
|
| Reference Values | 2 | 1991 | 704 | 0.020 |
Why?
|
| Ethers | 1 | 1992 | 9 | 0.020 |
Why?
|
| Catalase | 2 | 1990 | 64 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 1999 | 2438 | 0.020 |
Why?
|
| Arterial Pressure | 1 | 2013 | 128 | 0.020 |
Why?
|
| Hypotension | 2 | 2008 | 185 | 0.020 |
Why?
|
| Doppler Effect | 3 | 1980 | 4 | 0.020 |
Why?
|
| 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 1 | 2011 | 5 | 0.020 |
Why?
|
| Phentolamine | 2 | 1988 | 16 | 0.020 |
Why?
|
| Calcium Channel Agonists | 1 | 2011 | 11 | 0.020 |
Why?
|
| Superoxide Dismutase | 2 | 1990 | 176 | 0.020 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 2011 | 33 | 0.020 |
Why?
|
| Postoperative Period | 2 | 2009 | 334 | 0.020 |
Why?
|
| Antioxidants | 1 | 1994 | 333 | 0.020 |
Why?
|
| Indomethacin | 3 | 1990 | 82 | 0.020 |
Why?
|
| Mice, Inbred DBA | 3 | 1995 | 56 | 0.020 |
Why?
|
| Endocardium | 2 | 2008 | 56 | 0.020 |
Why?
|
| rho-Associated Kinases | 1 | 2011 | 51 | 0.020 |
Why?
|
| Cell Differentiation | 4 | 2001 | 1960 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 1994 | 516 | 0.020 |
Why?
|
| Sex Factors | 2 | 2005 | 1353 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 3 | 1986 | 258 | 0.020 |
Why?
|
| Electromagnetic Phenomena | 1 | 1990 | 6 | 0.020 |
Why?
|
| Lymph | 1 | 1990 | 7 | 0.020 |
Why?
|
| Thromboxane B2 | 1 | 1990 | 17 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2011 | 303 | 0.020 |
Why?
|
| alpha-Linolenic Acid | 1 | 2010 | 15 | 0.020 |
Why?
|
| Mammaplasty | 1 | 2010 | 41 | 0.020 |
Why?
|
| Autonomic Nervous System | 1 | 1990 | 50 | 0.020 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2010 | 22 | 0.020 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2010 | 68 | 0.020 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1990 | 52 | 0.020 |
Why?
|
| Cardiotonic Agents | 2 | 2001 | 136 | 0.020 |
Why?
|
| Arachidonic Acid | 1 | 2010 | 67 | 0.020 |
Why?
|
| Potassium Channel Blockers | 1 | 2010 | 86 | 0.020 |
Why?
|
| Mitochondria, Heart | 2 | 1981 | 53 | 0.020 |
Why?
|
| Ventricular Fibrillation | 1 | 1990 | 56 | 0.020 |
Why?
|
| Sheep | 1 | 1990 | 230 | 0.020 |
Why?
|
| Ascites | 1 | 1990 | 102 | 0.020 |
Why?
|
| Blood Proteins | 1 | 1990 | 137 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 1997 | 1610 | 0.020 |
Why?
|
| Kinetics | 6 | 1987 | 1129 | 0.020 |
Why?
|
| Ketamine | 1 | 1993 | 226 | 0.020 |
Why?
|
| Edema | 1 | 1990 | 143 | 0.020 |
Why?
|
| Radiation Chimera | 2 | 2001 | 18 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2010 | 189 | 0.020 |
Why?
|
| Acid-Base Equilibrium | 1 | 1988 | 60 | 0.020 |
Why?
|
| Atropine | 2 | 1985 | 26 | 0.020 |
Why?
|
| Phantoms, Imaging | 1 | 2009 | 133 | 0.020 |
Why?
|
| Postoperative Complications | 2 | 2009 | 3142 | 0.020 |
Why?
|
| Propanolamines | 1 | 2008 | 19 | 0.020 |
Why?
|
| Young Adult | 2 | 2015 | 9952 | 0.020 |
Why?
|
| Deferoxamine | 1 | 1987 | 7 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 1988 | 206 | 0.020 |
Why?
|
| Pyrazolones | 1 | 1987 | 2 | 0.020 |
Why?
|
| Lipoxygenase | 1 | 1987 | 3 | 0.020 |
Why?
|
| Thiourea | 1 | 1987 | 10 | 0.020 |
Why?
|
| Adrenergic beta-Agonists | 2 | 1985 | 78 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2008 | 223 | 0.020 |
Why?
|
| Acidosis | 1 | 1988 | 101 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2009 | 7100 | 0.020 |
Why?
|
| Action Potentials | 1 | 2010 | 494 | 0.020 |
Why?
|
| Models, Biological | 2 | 1983 | 1443 | 0.020 |
Why?
|
| Tiopronin | 1 | 1986 | 2 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2008 | 615 | 0.020 |
Why?
|
| Dwarfism | 1 | 2007 | 103 | 0.020 |
Why?
|
| Amino Acids, Sulfur | 1 | 1986 | 15 | 0.020 |
Why?
|
| Administration, Oral | 5 | 1987 | 698 | 0.020 |
Why?
|
| Heart Conduction System | 2 | 2004 | 167 | 0.020 |
Why?
|
| Pancreatectomy | 2 | 1984 | 149 | 0.020 |
Why?
|
| Pressoreceptors | 1 | 1986 | 9 | 0.020 |
Why?
|
| Reflex | 1 | 1986 | 35 | 0.020 |
Why?
|
| Angioplasty, Balloon | 1 | 1987 | 156 | 0.020 |
Why?
|
| Graft Survival | 2 | 2001 | 473 | 0.020 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1986 | 43 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2006 | 40 | 0.020 |
Why?
|
| Norepinephrine | 2 | 1984 | 166 | 0.020 |
Why?
|
| Pericardium | 1 | 1986 | 102 | 0.020 |
Why?
|
| CELF Proteins | 1 | 2005 | 14 | 0.010 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 1985 | 19 | 0.010 |
Why?
|
| Aged | 4 | 2009 | 21415 | 0.010 |
Why?
|
| Kidney | 6 | 1986 | 1330 | 0.010 |
Why?
|
| Cardiomyopathies | 2 | 2008 | 518 | 0.010 |
Why?
|
| Injections, Intra-Arterial | 1 | 2005 | 18 | 0.010 |
Why?
|
| Linear Models | 1 | 2007 | 713 | 0.010 |
Why?
|
| Stem Cell Factor | 2 | 1995 | 12 | 0.010 |
Why?
|
| Dexamethasone | 1 | 1986 | 274 | 0.010 |
Why?
|
| Chlorisondamine | 3 | 1990 | 4 | 0.010 |
Why?
|
| Penetrance | 1 | 2005 | 113 | 0.010 |
Why?
|
| Head and Neck Neoplasms | 1 | 2010 | 620 | 0.010 |
Why?
|
| Pyrazoles | 1 | 1987 | 332 | 0.010 |
Why?
|
| Contractile Proteins | 1 | 1984 | 17 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1986 | 224 | 0.010 |
Why?
|
| Fluorocarbons | 1 | 2005 | 58 | 0.010 |
Why?
|
| Thrombosis | 1 | 2009 | 524 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2007 | 602 | 0.010 |
Why?
|
| Constriction, Pathologic | 1 | 1985 | 235 | 0.010 |
Why?
|
| Bradykinin | 1 | 1984 | 50 | 0.010 |
Why?
|
| Artifacts | 1 | 2005 | 114 | 0.010 |
Why?
|
| Cell Division | 2 | 1995 | 743 | 0.010 |
Why?
|
| Pancreatic Polypeptide | 1 | 1983 | 6 | 0.010 |
Why?
|
| Genotype | 1 | 2010 | 2697 | 0.010 |
Why?
|
| Recombinant Proteins | 2 | 1999 | 1347 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2004 | 250 | 0.010 |
Why?
|
| Mathematics | 1 | 1983 | 85 | 0.010 |
Why?
|
| Depression, Chemical | 3 | 1989 | 37 | 0.010 |
Why?
|
| Multivariate Analysis | 2 | 2002 | 1439 | 0.010 |
Why?
|
| Consciousness | 4 | 1989 | 46 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2005 | 526 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2005 | 677 | 0.010 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 1984 | 145 | 0.010 |
Why?
|
| Collagen | 1 | 1984 | 303 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2006 | 697 | 0.010 |
Why?
|
| Blood Circulation | 2 | 1979 | 17 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2005 | 587 | 0.010 |
Why?
|
| Research Design | 1 | 2007 | 742 | 0.010 |
Why?
|
| Injections, Intraventricular | 3 | 1990 | 60 | 0.010 |
Why?
|
| Solvents | 1 | 2002 | 44 | 0.010 |
Why?
|
| Captopril | 1 | 2002 | 23 | 0.010 |
Why?
|
| Pancuronium | 1 | 1982 | 6 | 0.010 |
Why?
|
| Acute Disease | 2 | 1996 | 1160 | 0.010 |
Why?
|
| Oxygen | 1 | 1985 | 569 | 0.010 |
Why?
|
| Heart Septum | 1 | 2002 | 55 | 0.010 |
Why?
|
| Gene Expression | 2 | 1997 | 1558 | 0.010 |
Why?
|
| Tolbutamide | 1 | 1981 | 5 | 0.010 |
Why?
|
| Dopamine | 2 | 1981 | 253 | 0.010 |
Why?
|
| Rats, Inbred SHR | 1 | 2001 | 58 | 0.010 |
Why?
|
| Dietary Proteins | 1 | 1983 | 219 | 0.010 |
Why?
|
| Cell Transplantation | 1 | 2001 | 42 | 0.010 |
Why?
|
| Cardiology | 1 | 1986 | 498 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2001 | 139 | 0.010 |
Why?
|
| Acetylcholine | 1 | 2001 | 84 | 0.010 |
Why?
|
| Muscle Development | 1 | 2001 | 73 | 0.010 |
Why?
|
| Purinergic P1 Receptor Agonists | 1 | 2000 | 5 | 0.010 |
Why?
|
| Heart Arrest, Induced | 1 | 1981 | 77 | 0.010 |
Why?
|
| Rest | 1 | 1981 | 66 | 0.010 |
Why?
|
| Infusions, Parenteral | 3 | 1985 | 79 | 0.010 |
Why?
|
| Intraoperative Period | 2 | 1990 | 69 | 0.010 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2002 | 222 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 3089 | 0.010 |
Why?
|
| Brain | 2 | 1990 | 3175 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2001 | 329 | 0.010 |
Why?
|
| Hepatic Veins | 3 | 1985 | 21 | 0.010 |
Why?
|
| Neovascularization, Physiologic | 1 | 2001 | 210 | 0.010 |
Why?
|
| Carotid Artery, Internal | 1 | 1980 | 58 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2001 | 749 | 0.010 |
Why?
|
| Antimetabolites | 1 | 1999 | 30 | 0.010 |
Why?
|
| Chimera | 1 | 1999 | 83 | 0.010 |
Why?
|
| Catecholamines | 1 | 1979 | 52 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2001 | 327 | 0.010 |
Why?
|
| Fluorouracil | 1 | 1999 | 138 | 0.010 |
Why?
|
| Stem Cell Transplantation | 1 | 2001 | 249 | 0.010 |
Why?
|
| Palmitoyl Coenzyme A | 1 | 1979 | 1 | 0.010 |
Why?
|
| Phosphorylase b | 1 | 1979 | 3 | 0.010 |
Why?
|
| Palmitoylcarnitine | 1 | 1979 | 4 | 0.010 |
Why?
|
| Phosphorylases | 1 | 1979 | 7 | 0.010 |
Why?
|
| Microsurgery | 1 | 1979 | 62 | 0.010 |
Why?
|
| Acyl Coenzyme A | 1 | 1979 | 24 | 0.010 |
Why?
|
| Glycogen | 1 | 1979 | 53 | 0.010 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 1979 | 26 | 0.010 |
Why?
|
| Acyltransferases | 1 | 1979 | 45 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2001 | 1011 | 0.010 |
Why?
|
| Glutamates | 1 | 1979 | 69 | 0.010 |
Why?
|
| Carnitine | 1 | 1979 | 69 | 0.010 |
Why?
|
| Methods | 1 | 1978 | 126 | 0.010 |
Why?
|
| Calibration | 1 | 1978 | 99 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2008 | 6569 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 1694 | 0.010 |
Why?
|
| Blood Cell Count | 1 | 1997 | 68 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 2 | 1994 | 489 | 0.010 |
Why?
|
| Liver Glycogen | 1 | 1997 | 22 | 0.010 |
Why?
|
| Adolescent | 2 | 2009 | 20535 | 0.010 |
Why?
|
| Survival Rate | 1 | 2002 | 2192 | 0.010 |
Why?
|
| Coronary Artery Bypass | 2 | 1990 | 537 | 0.010 |
Why?
|
| Corrosion Casting | 1 | 1995 | 2 | 0.010 |
Why?
|
| Tetrazolium Salts | 1 | 1995 | 12 | 0.010 |
Why?
|
| Osteosclerosis | 1 | 1995 | 12 | 0.010 |
Why?
|
| Thyroxine | 1 | 1996 | 65 | 0.010 |
Why?
|
| Coloring Agents | 1 | 1995 | 76 | 0.010 |
Why?
|
| Thrombocytosis | 1 | 1995 | 34 | 0.010 |
Why?
|
| Fibrosis | 1 | 1997 | 421 | 0.010 |
Why?
|
| Nitrogen Oxides | 1 | 1995 | 5 | 0.010 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 1995 | 18 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2001 | 3037 | 0.010 |
Why?
|
| Cyclic N-Oxides | 1 | 1995 | 12 | 0.010 |
Why?
|
| Primary Myelofibrosis | 1 | 1995 | 53 | 0.010 |
Why?
|
| Retroviridae | 1 | 1995 | 193 | 0.010 |
Why?
|
| Y Chromosome | 1 | 1995 | 47 | 0.010 |
Why?
|
| Blood Cells | 1 | 1995 | 54 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 1995 | 49 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 2 | 1985 | 131 | 0.010 |
Why?
|
| Heart Diseases | 1 | 1979 | 513 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 2 | 1978 | 2554 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 2 | 1993 | 1221 | 0.010 |
Why?
|
| Risk Factors | 1 | 2009 | 10941 | 0.010 |
Why?
|
| Vascular Surgical Procedures | 1 | 1979 | 552 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 1995 | 346 | 0.010 |
Why?
|
| Back | 1 | 1993 | 11 | 0.010 |
Why?
|
| Angiography | 1 | 1974 | 208 | 0.010 |
Why?
|
| Cell Movement | 1 | 1997 | 888 | 0.010 |
Why?
|
| Cell Death | 1 | 1994 | 241 | 0.010 |
Why?
|
| Blood Gas Analysis | 1 | 1993 | 85 | 0.010 |
Why?
|
| Nitrous Oxide | 1 | 1992 | 13 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 1986 | 152 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1995 | 761 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1996 | 1233 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 1995 | 925 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 1974 | 485 | 0.010 |
Why?
|
| Angina, Unstable | 1 | 1991 | 52 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1995 | 1548 | 0.010 |
Why?
|
| Calcium | 1 | 1996 | 1078 | 0.010 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 1991 | 183 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 1995 | 803 | 0.010 |
Why?
|
| Decalcification Technique | 1 | 1969 | 2 | 0.000 |
Why?
|
| Edetic Acid | 1 | 1969 | 23 | 0.000 |
Why?
|
| Cadaver | 1 | 1969 | 119 | 0.000 |
Why?
|
| Reaction Time | 1 | 1990 | 167 | 0.000 |
Why?
|
| Iliac Artery | 1 | 1969 | 75 | 0.000 |
Why?
|
| Biomechanical Phenomena | 1 | 1990 | 229 | 0.000 |
Why?
|
| Partial Pressure | 1 | 1988 | 28 | 0.000 |
Why?
|
| Oxygen Consumption | 2 | 1981 | 305 | 0.000 |
Why?
|
| Receptors, Adrenergic | 1 | 1988 | 18 | 0.000 |
Why?
|
| Receptors, Vasopressin | 1 | 1988 | 14 | 0.000 |
Why?
|
| Arginine Vasopressin | 1 | 1988 | 28 | 0.000 |
Why?
|
| Lipoxygenase Inhibitors | 1 | 1987 | 6 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1988 | 448 | 0.000 |
Why?
|
| Dilatation, Pathologic | 1 | 1987 | 89 | 0.000 |
Why?
|
| Epinephrine | 1 | 1988 | 155 | 0.000 |
Why?
|
| Carbon Dioxide | 1 | 1988 | 275 | 0.000 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 1988 | 137 | 0.000 |
Why?
|
| Radiography | 1 | 1969 | 819 | 0.000 |
Why?
|
| Leukocyte Count | 1 | 1987 | 249 | 0.000 |
Why?
|
| Sulfates | 1 | 1985 | 35 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1979 | 8542 | 0.000 |
Why?
|
| Receptor, Insulin | 1 | 1985 | 68 | 0.000 |
Why?
|
| Dipyridamole | 1 | 1985 | 14 | 0.000 |
Why?
|
| Diatrizoate Meglumine | 1 | 1985 | 18 | 0.000 |
Why?
|
| Neutrophils | 1 | 1987 | 361 | 0.000 |
Why?
|
| Infusions, Intravenous | 1 | 1986 | 547 | 0.000 |
Why?
|
| Portal System | 1 | 1984 | 36 | 0.000 |
Why?
|
| Iron | 1 | 1987 | 302 | 0.000 |
Why?
|
| Adenosine Triphosphate | 1 | 1985 | 275 | 0.000 |
Why?
|
| Perfusion | 1 | 1985 | 208 | 0.000 |
Why?
|
| Drinking | 1 | 1984 | 29 | 0.000 |
Why?
|
| Diuresis | 1 | 1984 | 46 | 0.000 |
Why?
|
| Wakefulness | 1 | 1985 | 104 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1985 | 470 | 0.000 |
Why?
|
| Meat | 1 | 1983 | 45 | 0.000 |
Why?
|
| Anesthesia, General | 1 | 1983 | 124 | 0.000 |
Why?
|
| Nitroprusside | 1 | 1981 | 37 | 0.000 |
Why?
|
| Eating | 1 | 1983 | 381 | 0.000 |
Why?
|
| Electrophysiology | 1 | 1981 | 269 | 0.000 |
Why?
|
| Compliance | 1 | 1979 | 18 | 0.000 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1979 | 19 | 0.000 |
Why?
|
| Papillary Muscles | 1 | 1979 | 17 | 0.000 |
Why?
|
| Monitoring, Intraoperative | 1 | 1979 | 134 | 0.000 |
Why?
|
| Citric Acid Cycle | 1 | 1979 | 46 | 0.000 |
Why?
|
| Cardiopulmonary Bypass | 1 | 1981 | 373 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1981 | 1179 | 0.000 |
Why?
|
| Oxidation-Reduction | 1 | 1979 | 436 | 0.000 |
Why?
|
| Energy Metabolism | 1 | 1981 | 785 | 0.000 |
Why?
|
| Animals, Newborn | 1 | 1979 | 1033 | 0.000 |
Why?
|
| Stimulation, Chemical | 1 | 1975 | 43 | 0.000 |
Why?
|
| Cell Membrane Permeability | 1 | 1975 | 72 | 0.000 |
Why?
|
| Shock, Hemorrhagic | 1 | 1975 | 55 | 0.000 |
Why?
|